Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideto Tamura

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Experimental Hematology|August 21, 2020
The SLAMF3 rs509749 polymorphism correlates with malignant potential in multiple myelomaMariko Ishibashi, Mika Sunakawa-Kii, Yuta Kaito, et al.
Acta Haematologica|June 8, 2026
COVID-19 infection in patients with follicular lymphoma and related indolent B-cell lymphomas receiving anti-CD20 monoclonal antibody maintenance therapyShinto Kuniyoshi, Kohei Tanaka, Yu Akuzawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Functional B7.2 and B7-H2 molecules on myeloma cells are associated with a growth advantageTaishi Yamashita, Hideto Tamura, Chikako Satoh, et al.
International Journal of Hematology|February 27, 2007
Pure white cell aplasia: report of the first case associated with primary biliary cirrhosisHideto Tamura, Muneo Okamoto, Taishi Yamashita, et al.
Internal Medicine (Tokyo, Japan)|January 14, 2026
The Effectiveness of Elranatamab in the Management of Refractory Multiple Myeloma with Central Nervous System InvolvementMisaki Uemura, Atsushi Marumo, Atsushi Obata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemiaHideto Tamura, Kazuo Dan, Koji Tamada, et al.
Cancer Immunology Research|July 22, 2016
Myeloma Drug Resistance Induced by Binding of Myeloma B7-H1 (PD-L1) to PD-1Mariko Ishibashi, Hideto Tamura, Mika Sunakawa, et al.
Immunology|November 26, 2009
Leucocyte-associated immunoglobulin-like receptor-1 is an inhibitory regulator of contact hypersensitivityRyusuke Omiya, Fumihiko Tsushima, Hidehiko Narazaki, et al.
Haematologica|June 24, 2009
Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation studyKiyoyuki Ogata, Matteo G Della Porta, Luca Malcovati, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 11, 2015
[Evaluation of the enhanced International Prognostic Index (NCCN-IPI) for cases with diffuse large B-cell lymphoma]Akiko Yamada, Hideto Tamura, Toshio Asayama, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Experimental Hematology|August 21, 2020
The SLAMF3 rs509749 polymorphism correlates with malignant potential in multiple myelomaMariko Ishibashi, Mika Sunakawa-Kii, Yuta Kaito, et al.
Acta Haematologica|June 8, 2026
COVID-19 infection in patients with follicular lymphoma and related indolent B-cell lymphomas receiving anti-CD20 monoclonal antibody maintenance therapyShinto Kuniyoshi, Kohei Tanaka, Yu Akuzawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Functional B7.2 and B7-H2 molecules on myeloma cells are associated with a growth advantageTaishi Yamashita, Hideto Tamura, Chikako Satoh, et al.
International Journal of Hematology|February 27, 2007
Pure white cell aplasia: report of the first case associated with primary biliary cirrhosisHideto Tamura, Muneo Okamoto, Taishi Yamashita, et al.
Internal Medicine (Tokyo, Japan)|January 14, 2026
The Effectiveness of Elranatamab in the Management of Refractory Multiple Myeloma with Central Nervous System InvolvementMisaki Uemura, Atsushi Marumo, Atsushi Obata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemiaHideto Tamura, Kazuo Dan, Koji Tamada, et al.
Cancer Immunology Research|July 22, 2016
Myeloma Drug Resistance Induced by Binding of Myeloma B7-H1 (PD-L1) to PD-1Mariko Ishibashi, Hideto Tamura, Mika Sunakawa, et al.
Immunology|November 26, 2009
Leucocyte-associated immunoglobulin-like receptor-1 is an inhibitory regulator of contact hypersensitivityRyusuke Omiya, Fumihiko Tsushima, Hidehiko Narazaki, et al.
Haematologica|June 24, 2009
Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation studyKiyoyuki Ogata, Matteo G Della Porta, Luca Malcovati, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 11, 2015
[Evaluation of the enhanced International Prognostic Index (NCCN-IPI) for cases with diffuse large B-cell lymphoma]Akiko Yamada, Hideto Tamura, Toshio Asayama, et al.
Pageof 7